STUDYING THE TUMOR BUDDING IN COLORECTAL ADENOCARCINOMA
Main Article Content
Abstract
Introduction: Colorectal cancer is the most common malignant disease of the gastrointestinal tract with a high mortality rate. Tumor budding is an important prognostic factor associated with lymph node metastasis, distant metastasis, local recurrence, and reduced overall survival and disease-free survival. Objectives: To assess the tumor budding and its relation with several histopathological features. Material and Methods: A retrospective cross-sectional descriptive study was conducted on hematoxylin and eosin (H&E)-stained slides of 103 patients with primary colorectal adenocarcinoma who underwent tumor resection and regional lymph node dissection without preoperative chemoradiotherapy, from January 2017 to November 2018 at Hanoi Medical University Hospital. Data analysis was performed using SPSS version 20.0. A p-value of <0.05 was considered statistically significant. The study complied with the Declaration of Helsinki on ethical principles for medical research involving human subjects and was approved by the Biomedical Ethics Committee of Hanoi Medical University (IRB-VN922). Results: The mean age of patients was 62.96 ± 12.651 years, with the most common age group being 60–69 years (36.9%). Males accounted for a higher proportion than females (55.3% vs. 44.7%). The most common anatomical site was the rectum (32.0%). Most cases were of the conventional type of adenocarcinoma (82.5%), moderately differentiated (86.4%), and at pathological stage pT3 (53.4%). The overall lymph node metastasis rate was 41.7%, with metastasis to 1–3 lymph nodes being the most common (32.0%). Tumors at stages I, II, and III accounted for 5.8%, 52.4%, and 41.7% of cases, respectively. The rates of lymphovascular and perineural invasion were 38.8% and 36.9%, respectively. Tumor budding was classified into three levels: low (Bd1, 52.4%), intermediate (Bd2, 28.2%), and high (Bd3, 19.4%). High-grade tumor budding was more frequently observed in patients with lymph node metastasis, deeper invasion stage, lymphovascular invasion, and perineural invasion (p < 0.05). Conclusion: High-grade tumor budding is a poor prognostic factor in colorectal carcinoma.
Article Details
Keywords
Tumor budding, colorectal adenocarcinoma
References
2. Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299-1311. doi:10.1038/modpathol.2017.46.
3. Khuy Đoàn Minh, Mai Hoàng Thị Ngọc, và Hạnh Bùi Thị Mỹ. Nảy chồi u: Một số yếu tố mô bệnh học mới trong ung thư biểu mô đại trực tràng. Tạp Chí Học Lâm Sàng. 2021; 120, 89–95.
4. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8. doi:10.1111/his.13975.
5. Weiser MR. AJCC 8th Edition: Colorectal cancer. Ann Surg Oncol. 2018;25(6):1454–5. doi:10. 1245/s10434-018-6462-1.
6. Nghi Phạm Hiện Đình, Minh Đỗ Đạt, Bình Nguyễn Như và cộng sự. Đặc điểm lâm sàng, sự nảy chồi u và mô bệnh học của ung thư biểu mô đại - trực tràng tại Bệnh viện ung bướu Cần Thơ và Bệnh viện Đại học Y dược Cần Thơ năm 2022-2023. Tạp Chí Dược Học Cần Thơ. 2024; 71, 89–95.
7. van Wyk H.C., Roseweir A., Alexander P. và cộng sự. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer. Ann Surg Oncol. 2019; 26(13), 4397–4404.